Journey Medical Corporation (DERM)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$5.26
-0.10%
Mkt Cap $184.86M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 25, 2026 | $18.85M | $16.08M | -14.71% | -$0.06 | -$0.04 | +33.33% | — | — |
| Q4 2025 Nov 12, 2025 | $18.86M | $17.63M | -6.53% | -$0.08 | -$0.09 | -12.50% | — | — |
| Q3 2025 Aug 12, 2025 | $18.90M | $15.01M | -20.60% | -$0.07 | -$0.16 | -128.57% | — | — |
| Q2 2025 May 14, 2025 | $14.93M | $13.14M | -12.01% | -$0.24 | -$0.18 | +25.00% | — | — |
| Q1 2025 Mar 26, 2025 | $12.05M | $13.62M | +12.99% | -$0.22 | $0.08 | +136.36% | — | — |
| Q4 2024 Nov 12, 2024 | $14.21M | $14.63M | +2.93% | -$0.17 | -$0.12 | +29.41% | — | — |
| Q3 2024 Aug 12, 2024 | $14.39M | $14.86M | +3.23% | -$0.15 | -$0.17 | -13.33% | — | — |
| Q2 2024 May 13, 2024 | $14.11M | $13.03M | -7.62% | -$0.26 | -$0.53 | -103.85% | — | — |
| Q1 2024 Mar 21, 2024 | $15.06M | $15.26M | +1.31% | -$0.08 | -$0.12 | -50.00% | — | — |
| Q4 2023 Nov 7, 2023 | $15.53M | $34.54M | +122.40% | -$0.15 | $0.80 | +633.33% | — | — |
| Q3 2023 Aug 8, 2023 | $15.16M | $17.17M | +13.27% | -$0.34 | -$0.46 | -35.29% | — | — |
| Q2 2023 May 22, 2023 | $15.07M | $12.21M | -18.96% | -$0.44 | -$0.57 | -29.55% | — | — |
| Q1 2023 Mar 29, 2023 | $16.18M | $15.97M | -1.32% | -$0.37 | -$0.60 | -62.16% | — | — |
| Q4 2022 Nov 10, 2022 | $16.58M | $16.12M | -2.80% | -$0.34 | -$0.57 | -67.65% | — | — |
| Q3 2022 Aug 9, 2022 | $21.30M | $18.29M | -14.13% | -$0.25 | -$0.43 | -72.00% | — | — |
| Q2 2022 May 10, 2022 | $22.16M | $23.30M | +5.11% | -$0.18 | -$0.08 | +55.56% | — | — |
| Q1 2022 Mar 23, 2022 | $20.39M | $17.52M | -14.08% | -$0.29 | -$1.64 | -465.52% | — | — |
| Q4 2021 Dec 10, 2021 | $13.35M | $19.61M | +46.89% | -$0.87 | -$1.16 | -33.57% | — | — |
| Q4 2021 Nov 12, 2021 | — | $15.29M | — | — | -$1.30 | — | — | — |
| Q1 2021 Mar 31, 2021 | — | $10.72M | — | — | $0.03 | — | — | — |